Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer
Clinical trial NCT06149130 · RECRUITING
Trial details
- NCT number
- NCT06149130
- Sponsor
- Tongji Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-11
- Primary completion
- 2025-11-30
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.